GIMAP5 and hepatocellular carcinoma: Furthermore, on a recent study performed on hepatocellular carcinoma (HCC), Huang et al. found that the mRNA expression of GIMAP5 and GIMAP6 were significantly downregulated in the HCC tumor samples and in the blood samples from HCC patients in comparison to matched non-tumor tissue samples, and blood from healthy subjects25.